Technical Analysis for AZN - Astrazeneca Plc

Grade Last Price % Change Price Change
C 10678.00 -0.60% -64.00
AZN closed down 0.6 percent on Thursday, March 28, 2024, on 49 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 200 DMA Bullish -0.60%
Expansion Breakout Bullish Swing Setup -0.60%
Stochastic Reached Overbought Strength -0.60%
Above Upper BB Strength -0.60%
Overbought Stochastic Strength -0.60%
Upper Bollinger Band Touch Strength -0.60%
Gapped Down Weakness 2.73%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Astrazeneca Plc Description

AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVMD, it is expanding its portfolio into the cardiovascular-renal area with late-stage assets, such as ZS-9 and roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). The Company has approximately 40 projects in Phase I, including 29 new molecular entities (NMEs), and 11 oncology combination projects. It has approximately 40 projects in Phase II, including 25 NMEs; four significant additional indications for projects that have reached phase II, and seven oncology combination projects.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Pharmaceutical Natural Sciences Science Life Sciences Disease Biopharmaceutical Oncology Pharmacy Pharmaceutical Industry Therapy Franchises Infection Respirator Therapies E Card Molecular Astrazeneca Neuroscience Heart Failure Kidney Disease Chronic Kidney Disease Södertälje Municipality

Is AZN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12389.2908
52 Week Low 9461.5387
Average Volume 2,614,449
200-Day Moving Average 10551.89
50-Day Moving Average 10270.72
20-Day Moving Average 10334.70
10-Day Moving Average 10414.00
Average True Range 173.36
RSI (14) 61.83
ADX 13.96
+DI 37.04
-DI 18.96
Chandelier Exit (Long, 3 ATRs) 10259.92
Chandelier Exit (Short, 3 ATRs) 10502.08
Upper Bollinger Bands 10703.84
Lower Bollinger Band 9965.56
Percent B (%b) 0.96
BandWidth 7.14
MACD Line 95.37
MACD Signal Line 52.40
MACD Histogram 42.9706
Fundamentals Value
Market Cap 165.53 Billion
Num Shares 1.55 Billion
EPS 3.02
Price-to-Earnings (P/E) Ratio 3535.76
Price-to-Sales 3.32
Price-to-Book 4.88
PEG Ratio 0.47
Dividend 2.90
Dividend Yield 0.03%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10837.00
Resistance 3 (R3) 10853.33 10816.67 10810.50
Resistance 2 (R2) 10816.67 10776.17 10808.50 10801.66
Resistance 1 (R1) 10747.33 10751.16 10729.00 10731.00 10792.83
Pivot Point 10710.67 10710.67 10701.50 10702.50 10710.67
Support 1 (S1) 10641.33 10670.17 10623.00 10625.00 10563.17
Support 2 (S2) 10604.67 10645.16 10596.50 10554.34
Support 3 (S3) 10535.33 10604.67 10545.50
Support 4 (S4) 10519.00